Taylor R N, Fulford K M
J Clin Microbiol. 1981 Feb;13(2):356-68. doi: 10.1128/jcm.13.2.356-368.1981.
The data accumulated from 1969 to 1979 in the Diagnostic Immunology portion of the Center for Disease Control Proficiency Testing Program were evaluated for evidence of change in performance among the participating laboratories. Evidence of improved performance was found for the rubella, rheumatoid factor, tularemia, quantitative immunoglobulin (immunoglobulin G, A, and M), and hepatitis B tests. No evidence of change was detected for the streptococcal enzyme, C-reactive protein, infectious mononucleosis, antinuclear antibodies, Salmonella and Brucella agglutinins, and syphilis tests. Data obtained from other tests were inadequate to determine trends. In most tests, deficiencies were identified which could be corrected and thereby could improve performance. It is pointed out that proficiency testing not only improves laboratory performance, but also can be used to evaluate performance levels, identify method, standard, or performance deficiencies, educate, estimate impact of possible changes, serve as external quality control, and document changes.
对疾病控制中心能力验证计划诊断免疫学部分在1969年至1979年期间积累的数据进行了评估,以寻找参与实验室的检测表现变化的证据。风疹、类风湿因子、土拉菌病、定量免疫球蛋白(免疫球蛋白G、A和M)以及乙肝检测显示有表现改善的证据。链球菌酶、C反应蛋白、传染性单核细胞增多症、抗核抗体、沙门氏菌和布鲁氏菌凝集素以及梅毒检测未发现变化证据。从其他检测获得的数据不足以确定趋势。在大多数检测中,发现了可以纠正从而改善表现的不足之处。指出能力验证不仅能提高实验室表现,还可用于评估表现水平、识别方法、标准或表现缺陷、开展教育、估计可能变化的影响、作为外部质量控制以及记录变化情况。